Clamoxyquin
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101639This classification denotes an antiprotozoal agent with the molecular formula C17H24ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JUN13FZ6RF, chemically known as cn-17,900-2b but generally known as clamoxyquin, which bears US NIH Compound Identifier 18029. European Medicines Agency schedules Clamoxyquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06637MIG. The term CLAMOXYQUINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). As of Q4 2014, CLAMOXYQUIN remains the US FDA Preferred Term for this commodity. Clamoxyquin bears US NLM identifiers UMLS ID C2699337 and NCI Concept Code C78097. SMILES: CCN(CC)CCCNCC1=CC(=C2C=CC=NC2=C1O)CL.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.